MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Genetic, biochemical and clinical findingss in Friedreich’s ataxia patients – relationship with the disease severity

    R. Moganty, D. Pathak, A. srivastava, s. Gulati (New Delhi, India)

    Objective: To investigate the correlation of disease severity in terms of clinical, genetic and molecular parameters in FRDA. Background: : Friedreich ataxia (FRDA) is a…
  • MDS Virtual Congress 2020

    The use of Virtual Reality to Assess the Quality of Life in Patients with Spinocerebellar Ataxia

    B. Zeigelboim, B. Cavalcante-Leao, J.M Malisky, G.S Santos, M.S Severiani, H.T Teive (Curitiba, Brazil)

    Objective: To assess independence, confidence and balance for  development daily activities in patients with SCAs, before and after rehabilitation with virtual reality (ViR). Background: Spinocerebellar…
  • MDS Virtual Congress 2020

    Deutetrabenazine Reduces Involuntary Movements in Patients Most Severely Impacted by Tardive Dyskinesia in a 3-year Open-Label Extension Trial

    J. Bona, H. Barkay, A. Wilhelm, N. Chaijale, M. Gordon (Atlanta, GA, USA)

    Objective: To evaluate the efficacy of deutetrabenazine (DTBZ) in reducing TD in the most severely impacted patients using data from an ongoing open-label extension (OLE)…
  • MDS Virtual Congress 2020

    Substantia nigra echogenicity as a predictor of drug withdrawal response in suspected drug-induced parkinsonism: a five year follow-up study

    B. Baena Álvarez, R. Sainz Amo, F. Rodríguez Jorge, J. Gómez Corral, F.J Buisán Catevilla, N. García Barragán, I. Corral Corral, A. Felipe Mimbrera, M.C Matute Lozano, J. Masjuán Vallejo, J.C Martínez Castillo, J.L López-Sendón, A. Alonso Cánovas (Madrid, Spain)

    Objective: To asses the role of transcranial sonography in suspected drug-induced parkinsonism. Background: Differential diagnosis between drug-induced parkinsonism (DIP) and Parkinson’s disease (PD) is challenging,…
  • MDS Virtual Congress 2020

    Patient experiences of cervical dystonia management with botulinum toxin A: A comparison of US versus European survey findings

    C. Comella, J. Ferreira, M. Azoulai, E. Pain, S. Om (Chicago, IL, USA)

    Objective: Evaluate differences in the botulinum neurotoxin type A (BoNT-A) treatment experience between patients with cervical dystonia (CD) treated in the United States (US) versus…
  • MDS Virtual Congress 2020

    Mutation screening and clinical features analysis in patients with early-onset primary dystonia

    X.J Gu, J. Yang, L.Y Zhang, QQ. Wei, H.F Shang (Chengdu, China)

    Objective: In this context, it is important to reveal the mutation frequency of primary dystonia related genes using target dystonia related gene panel among a…
  • MDS Virtual Congress 2020

    Late-Onset Dopa-Responsive Dystonia: A Case Report

    O. Oztop Cakmak, S. Ertan, S. Tekgul, N. Basak (Istanbul, Turkey)

    Objective: To present a rare cause of treatable dystonia with onset during adulthood. Background: L-Dopa-responsive dystonia is an inherited disorder characterized by early-onset dystonia affecting…
  • MDS Virtual Congress 2020

    An aberrant embouchure dystonia network predicts objective and functional measures of severity

    A. Morris, S. Norris, B. Adeyemo, S. Petersen, A. Snyder, J. Perlmutter, J. Mink (Rochester, NY, USA)

    Objective: To investigate functional brain networks underlying focal embouchure dystonia (FED) using resting-state functional connectivity (FC) magnetic resonance imaging and to correlate abnormal connectivity with…
  • MDS Virtual Congress 2020

    What is holding back apomorphine therapy for Parkinson’s disease? Identifying knowledge gaps amongst Thai neurological medical professionals

    O. Phokaewvarangkul, K. Boonpang, N. Kantachadvanich, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To assess the level of understanding about, and identify knowledge gaps in, apomorphine therapy amongst Thai neurological medical professionals. Background: Continuous subcutaneous apomorphine infusion…
  • MDS Virtual Congress 2020

    Parkinson’s Disease in the Middle East, North Africa and South Asia: A Scoping Review

    H. Khalil, J. Siddiqui, L. Chahine, Z. Aldaajani, M. Abu Al-Melh, F. Abdullah, H. Amer, M. Ben Djebara, M. Salari, S. Khan, W. Regragui, M. Abu Snineh, S. Mittat, J. Bajwa (Irbid, Jordan)

    Objective: To summarize the literature on PD in the Middle East, North Africa and South Asia (MENASA) countries including its epidemiology, clinical characteristics and unique…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley